Decline in case rates of youth onset type 2 diabetes in year three of the COVID-19 pandemic.
J Pediatr Endocrinol Metab
; 37(4): 360-362, 2024 Apr 25.
Article
em En
| MEDLINE
| ID: mdl-38410000
ABSTRACT
OBJECTIVES:
To determine changes in case rates of youth onset type 2 diabetes in the three years following the COVID-19 pandemic.METHODS:
A single-center, retrospective medical record review was conducted for patients newly diagnosed with T2D between 3/1/18 and 2/28/23 at a pediatric tertiary care center. The number of patients referred to CHLA with a T2D diagnosis date between 3/1/2020 and 2/28/2023 was compared to historical rates between 3/1/2018 and 2/29/2020. χ2 or Fisher's exact test was used to compare categorical variables between each year and 2019.RESULTS:
Compared to prepandemic baseline (3/1/19-2/29/20, 11.8±3.7 cases/month), there was a significant increase in new T2D monthly case rates in pandemic year 1 (3/1/20-2/28/21, 20.1±6.0 cases/month, 171â¯%, p=0.005) and pandemic year 2 (3/1/21-2/28/22, 25.9±8.9 cases/month, 221â¯%, p=0.002). Case rates declined in pandemic year 3 to 14.5±4.1 cases/month (3/1/22-2/28/23, p=0.43). Compared to prepandemic year 1, the frequency of DKA at diagnosis was higher in pandemic year 1 (13.3 vs. 5.0â¯%, p=0.009). The DKA rate in pandemic years 2 (6.8â¯%) and 3 (3.4â¯%) were comparable to prepandemic year 1 (p=0.53 and 0.58, respectively).CONCLUSIONS:
Youth onset type 2 diabetes cases and DKA rates in year 3 of the pandemic have returned to prepandemic level.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Cetoacidose Diabética
/
Diabetes Mellitus Tipo 2
/
COVID-19
Limite:
Adolescent
/
Child
/
Humans
Idioma:
En
Revista:
J Pediatr Endocrinol Metab
Assunto da revista:
ENDOCRINOLOGIA
/
PEDIATRIA
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Estados Unidos